* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Homogeneous GTP Binding Assay For G
Survey
Document related concepts
CCR5 receptor antagonist wikipedia , lookup
Drug discovery wikipedia , lookup
Discovery and development of cephalosporins wikipedia , lookup
5-HT3 antagonist wikipedia , lookup
Toxicodynamics wikipedia , lookup
Discovery and development of angiotensin receptor blockers wikipedia , lookup
NMDA receptor wikipedia , lookup
Discovery and development of tubulin inhibitors wikipedia , lookup
Cannabinoid receptor antagonist wikipedia , lookup
Drug design wikipedia , lookup
Discovery and development of antiandrogens wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
NK1 receptor antagonist wikipedia , lookup
Transcript
Homogeneous GTP Binding Assay For G-protein Coupled Receptors Based on TR-FRET Heini Frang, Pertti Hurskainen, Veli-Matti Mukkala and Ilkka Hemmilä PerkinElmer Life and Analytical Sciences, Wallac Oy, P.O.Box 10, FIN-20101 Turku, Finland 4 Assay protocol (final volume 40 µl/well): - pipet all assay components into the white 384-microtitration plate: * reaction buffer with muscarinic M2 receptor contained 50 mM Hepes (pH 7.4), 10 µM GDP, 5 mM MgCl2, 10 mM NaCl and 0.05% TSA-BSA. * M2 cell membrane concentration 10 µg/well * KaroBio’s bio-peptide (10-40 nM) * SA-Eu (W1024 or W8044 from PerkinElmer) (0.5-5 nM) * Alexa647-GTP (10-50 nM) * ± different concentrations of suitable agonist * ± 5 µM GTPγS to detect non-specific binding * incubation at RT for ~30 min * measured in VICTOR2TMV multilabel counter using factory-set LANCE protocol RESULTS 5 nM 3.5 For the TR-FRET GTP binding assay Alexa647 (Molecular Probes) was coupled to the γphosphate of GTP. Muscarinic M2 receptor was over expressed with Gαi proteins in Sf9 cells and the cell membrane fraction was used in the assay. Biotinylated BioKey® peptide probe recognizing the Gαi subunit in a GTP bound conformation was kindly provided by KaroBio. S/B ratio G-protein coupled receptors (GPCRs) represent one of the most important drug discovery targets since the compounds targeted against GPCRs form the largest drug class currently on the market. General trend within HTS screening arena favours functional assays when searching new lead molecules for GPCR candidate drugs. One considerable functional assay to monitor GPCR activation is the cell membrane based GTP binding assay. Agonist binding to GPCRs stimulates the guanine nucleotide exchange, GDP bound to Gα subunit of heterotrimeric Gproteins, dissociates and is replaced by GTP. Karo Bio’s AlphaKey™ technology is based on BioKey® peptide probes that e.g. specifically bind to the Gαi subunit in a conformationdependent manner. In our TR-FRET model system we have used biotinylated BioKey® peptide recognizing only the GTP bound form of the Gα subunit. Biotinylated peptide enables binding of SA-Eu into close proximity of the acceptor labelled GTP bound also to the Gα subunit. TR-FRET GTP binding assay is a homogeneous all-in-one assay highly applicable to HTS screening for agonists of GPCRs. [bio-peptide] 4.0 5 10 nM 3.0 Figure legend: the effect of different bio-peptide : SA ratios to the S/B ratio. This optimization step was performed in the M2 receptor reaction buffer with 10 nM Alexa647GTP and 10 µg/wel cell membranes. Stimulation was done with 100 µM bethanecol for 30 min at RT. 20 nM 40 nM 2.5 2.0 1.5 1.0 0.8 1.6 3.2 [SA-Eu (W1024)] (nM) 6 Figure legend: dose-response curves with SA labelled with different Eu chelates (A) with SA-W1024 and B) with SA-W8044). Assay conditions were: M2 receptor reaction buffer with 10 µg/wel cell membranes, 10 nM Alexa647-GTP, 40 nM bio-peptide and 1 nM SA-Eu (W1024). B) Assay conditions like above except 50 nM Alexa647-GTP and 0.8 nM SA-Eu (W8044) was used. Incubation times and EC50 values showed in the figure. 10 min; 16.3 µM A 300 250 2 B 200 40 min; 6.7 µM 50 min; 8.2 µM 100 60 min; 4.7 µM 50 log [bethanecol] (M) α 665 nm Eu βγ BIO SA Schematic presentation of the assay 340 nm 7 60 min; 8.6 µM 50 0 -3 50 min; 10.3 µM 100 -50 -5 40 min; 12.4 µM 150 0 -7 30 min; 14.9 µM 200 -50 -9 20 min; 16.8 µM 250 30 min; 7.4 µM 150 10 min; 38.2 µM 300 20 min; 9.5 µM % over basal METHODS 3 INTRODUCTION % over basal 1 -9 -7 -5 -3 log [bethanecol] (M) CONCLUSIONS • this new GTP binding assay based on TR-FRET and KaroBio’s conformation specific peptide shows agonist concentration dependent signal increase which is replaceable with GTPγS. • we are still in the middle of optimization process and future goal is to be able to use membranes from mammalian cell lines in the assay. • assay is easily applicable to automation and therefore suitable for HTS screening. PerkinElmer Life and Analytical Sciences, 710 Bridgeport Avenue, Shelton, CT USA (800) 762-4000 (+1) 203 925-4602 www.perkinelmer.com